The Aurora-A-Twist1 axis promotes highly aggressive phenotypes in pancreatic carcinoma

Jing Wang, Kumar Nikhil, Keith Viccaro, Lei Chang, Max Jacobsen, George Sandusky, Kavita Shah

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

We uncovered a crucial role for the Aurora kinase A (AURKA)- Twist1 axis in promoting epithelial-to-mesenchymal transition (EMT) and chemoresistance in pancreatic cancer. Twist1 is the first EMT-specific target of AURKA that was identified using an innovative screen. AURKA phosphorylates Twist1 at three sites, which results in its multifaceted regulation - AURKA inhibits its ubiquitylation, increases its transcriptional activity and favors its homodimerization. Twist1 reciprocates and prevents AURKA degradation, thereby triggering a feedback loop. Ablation of either AURKA or Twist1 completely inhibits EMT, highlighting both proteins as central players in EMT progression. Phosphorylation-dead Twist1 serves as a dominant-negative and fully reverses the EMT phenotype induced by Twist1, underscoring the crucial role of AURKA-mediated phosphorylation in mediating Twist1-induced malignancy. Likewise, Twist1-overexpressing BxPC3 cells formed large tumors in vivo, whereas expression of phosphorylation-dead Twist1 fully abrogated this effect. Furthermore, immunohistochemical analysis of pancreatic cancer specimens revealed a 3-fold higher level of Twist1 compared to that seen in healthy normal tissues. This is the first study that links Twist1 in a feedback loop with its activating kinase, which indicates that concurrent inhibition of AURKA and Twist1 will be synergistic in inhibiting pancreatic tumorigenesis and metastasis.

Original languageEnglish (US)
Pages (from-to)1078-1093
Number of pages16
JournalJournal of Cell Science
Volume130
Issue number6
DOIs
StatePublished - 2017

Fingerprint

Aurora Kinase A
Epithelial-Mesenchymal Transition
Phenotype
Phosphorylation
Pancreatic Neoplasms
Pancreatic Carcinoma
Ubiquitination
Neoplasms
Carcinogenesis
Phosphotransferases
Neoplasm Metastasis

Keywords

  • AURKA
  • Drug discovery
  • EMT
  • Pancreatic cancer
  • Therapy
  • Twist1

ASJC Scopus subject areas

  • Cell Biology

Cite this

The Aurora-A-Twist1 axis promotes highly aggressive phenotypes in pancreatic carcinoma. / Wang, Jing; Nikhil, Kumar; Viccaro, Keith; Chang, Lei; Jacobsen, Max; Sandusky, George; Shah, Kavita.

In: Journal of Cell Science, Vol. 130, No. 6, 2017, p. 1078-1093.

Research output: Contribution to journalArticle

Wang, J, Nikhil, K, Viccaro, K, Chang, L, Jacobsen, M, Sandusky, G & Shah, K 2017, 'The Aurora-A-Twist1 axis promotes highly aggressive phenotypes in pancreatic carcinoma', Journal of Cell Science, vol. 130, no. 6, pp. 1078-1093. https://doi.org/10.1242/jcs.196790
Wang, Jing ; Nikhil, Kumar ; Viccaro, Keith ; Chang, Lei ; Jacobsen, Max ; Sandusky, George ; Shah, Kavita. / The Aurora-A-Twist1 axis promotes highly aggressive phenotypes in pancreatic carcinoma. In: Journal of Cell Science. 2017 ; Vol. 130, No. 6. pp. 1078-1093.
@article{7103ba21e4dc411ba0b4338f2b03495a,
title = "The Aurora-A-Twist1 axis promotes highly aggressive phenotypes in pancreatic carcinoma",
abstract = "We uncovered a crucial role for the Aurora kinase A (AURKA)- Twist1 axis in promoting epithelial-to-mesenchymal transition (EMT) and chemoresistance in pancreatic cancer. Twist1 is the first EMT-specific target of AURKA that was identified using an innovative screen. AURKA phosphorylates Twist1 at three sites, which results in its multifaceted regulation - AURKA inhibits its ubiquitylation, increases its transcriptional activity and favors its homodimerization. Twist1 reciprocates and prevents AURKA degradation, thereby triggering a feedback loop. Ablation of either AURKA or Twist1 completely inhibits EMT, highlighting both proteins as central players in EMT progression. Phosphorylation-dead Twist1 serves as a dominant-negative and fully reverses the EMT phenotype induced by Twist1, underscoring the crucial role of AURKA-mediated phosphorylation in mediating Twist1-induced malignancy. Likewise, Twist1-overexpressing BxPC3 cells formed large tumors in vivo, whereas expression of phosphorylation-dead Twist1 fully abrogated this effect. Furthermore, immunohistochemical analysis of pancreatic cancer specimens revealed a 3-fold higher level of Twist1 compared to that seen in healthy normal tissues. This is the first study that links Twist1 in a feedback loop with its activating kinase, which indicates that concurrent inhibition of AURKA and Twist1 will be synergistic in inhibiting pancreatic tumorigenesis and metastasis.",
keywords = "AURKA, Drug discovery, EMT, Pancreatic cancer, Therapy, Twist1",
author = "Jing Wang and Kumar Nikhil and Keith Viccaro and Lei Chang and Max Jacobsen and George Sandusky and Kavita Shah",
year = "2017",
doi = "10.1242/jcs.196790",
language = "English (US)",
volume = "130",
pages = "1078--1093",
journal = "Journal of Cell Science",
issn = "0021-9533",
publisher = "Company of Biologists Ltd",
number = "6",

}

TY - JOUR

T1 - The Aurora-A-Twist1 axis promotes highly aggressive phenotypes in pancreatic carcinoma

AU - Wang, Jing

AU - Nikhil, Kumar

AU - Viccaro, Keith

AU - Chang, Lei

AU - Jacobsen, Max

AU - Sandusky, George

AU - Shah, Kavita

PY - 2017

Y1 - 2017

N2 - We uncovered a crucial role for the Aurora kinase A (AURKA)- Twist1 axis in promoting epithelial-to-mesenchymal transition (EMT) and chemoresistance in pancreatic cancer. Twist1 is the first EMT-specific target of AURKA that was identified using an innovative screen. AURKA phosphorylates Twist1 at three sites, which results in its multifaceted regulation - AURKA inhibits its ubiquitylation, increases its transcriptional activity and favors its homodimerization. Twist1 reciprocates and prevents AURKA degradation, thereby triggering a feedback loop. Ablation of either AURKA or Twist1 completely inhibits EMT, highlighting both proteins as central players in EMT progression. Phosphorylation-dead Twist1 serves as a dominant-negative and fully reverses the EMT phenotype induced by Twist1, underscoring the crucial role of AURKA-mediated phosphorylation in mediating Twist1-induced malignancy. Likewise, Twist1-overexpressing BxPC3 cells formed large tumors in vivo, whereas expression of phosphorylation-dead Twist1 fully abrogated this effect. Furthermore, immunohistochemical analysis of pancreatic cancer specimens revealed a 3-fold higher level of Twist1 compared to that seen in healthy normal tissues. This is the first study that links Twist1 in a feedback loop with its activating kinase, which indicates that concurrent inhibition of AURKA and Twist1 will be synergistic in inhibiting pancreatic tumorigenesis and metastasis.

AB - We uncovered a crucial role for the Aurora kinase A (AURKA)- Twist1 axis in promoting epithelial-to-mesenchymal transition (EMT) and chemoresistance in pancreatic cancer. Twist1 is the first EMT-specific target of AURKA that was identified using an innovative screen. AURKA phosphorylates Twist1 at three sites, which results in its multifaceted regulation - AURKA inhibits its ubiquitylation, increases its transcriptional activity and favors its homodimerization. Twist1 reciprocates and prevents AURKA degradation, thereby triggering a feedback loop. Ablation of either AURKA or Twist1 completely inhibits EMT, highlighting both proteins as central players in EMT progression. Phosphorylation-dead Twist1 serves as a dominant-negative and fully reverses the EMT phenotype induced by Twist1, underscoring the crucial role of AURKA-mediated phosphorylation in mediating Twist1-induced malignancy. Likewise, Twist1-overexpressing BxPC3 cells formed large tumors in vivo, whereas expression of phosphorylation-dead Twist1 fully abrogated this effect. Furthermore, immunohistochemical analysis of pancreatic cancer specimens revealed a 3-fold higher level of Twist1 compared to that seen in healthy normal tissues. This is the first study that links Twist1 in a feedback loop with its activating kinase, which indicates that concurrent inhibition of AURKA and Twist1 will be synergistic in inhibiting pancreatic tumorigenesis and metastasis.

KW - AURKA

KW - Drug discovery

KW - EMT

KW - Pancreatic cancer

KW - Therapy

KW - Twist1

UR - http://www.scopus.com/inward/record.url?scp=85015187484&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015187484&partnerID=8YFLogxK

U2 - 10.1242/jcs.196790

DO - 10.1242/jcs.196790

M3 - Article

VL - 130

SP - 1078

EP - 1093

JO - Journal of Cell Science

JF - Journal of Cell Science

SN - 0021-9533

IS - 6

ER -